Numerous UT MD Anderson Meet the Experts are scheduled throughout ASCO. Note: All times are listed in Central Time.
Saturday, May 30
9:45¨C10:15 a.m.
Advances in lymphoma and multiple myeloma
Andrew Harkins, M.D.
Fellow, Cancer Medicine
Associate Professor, Lymphoma and Myeloma
10:30¨C11 a.m.
Preventive ethics in oncology
Associate Vice President, Clinical Ethics and Goal?Concordant Care
Associate Professor, Critical Care Medicine
11¨C11:30 a.m.
Partnering with health systems to eliminate cancer
Andres Alvarez, M.D., Ph.D.
Baptist MD Anderson Cancer Center
Sumeet Bhatia, M.D.
Community Health Network MD Anderson Cancer Center
Jamin Morrison, M.D.
MD Anderson Cancer Center at Cooper
Director, Leukemia for Cancer Network
Lei Zheng, M.D., Ph.D.
UT Health San Antonio MD Anderson Cancer Center
11:30 a.m.¨C12 p.m.
Clinical trials at UT MD Anderson
Division Head, Cancer Medicine
Chief Clinical Research Officer
Professor, Breast Medical Oncology
12:15¨C12:45 p.m.
Post-surgery management of brain metastases (Abstract LBA2000)
Professor, Melanoma Medical Oncology
Deputy Chair and Professor, Neurosurgery
1¨C1:30 p.m.
Spotlight on sarcoma, Part I
Professor, Sarcoma Medical Oncology
Assistant Professor, Sarcoma Medical Oncology
1:30¨C2 p.m.
Psychedelic-assisted therapies in oncology
Assistant Professor, Head and Neck Surgery
Assistant Professor, Genomic Medicine
3¨C3:30 p.m.
New horizons in kidney cancer treatment
Assistant Professor, Genitourinary Medical Oncology
Professor, Genitourinary Medical Oncology
Associate Professor, Genitourinary Medical Oncology
3¨C5 p.m.
UT MD Anderson President
Peter WT Pisters, M.D.
President
3:30¨C4 p.m.
KRAS: Not just one target, Part I
Professor, Gastrointestinal Medical Oncology
4:15¨C4:45 p.m.
Practice-changing advances for non-small cell lung cancer
Chair and Professor, Thoracic/Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
Sunday, May 31
9¨C9:30 a.m.
The UT MD Anderson research enterprise
Chief Scientific Officer
Emily Roarty, Ph.D.
Vice President, Research Strategy and Impact
9:30¨C10 a.m.
Accelerating discoveries with industry partnerships
Emily Barnhill
Vice President, Strategic Industry Ventures
Aaron Spike
Director, Strategic Industry Ventures
9:30¨C10 a.m.
Advances in targeted therapy in leukemia
Associate Professor, Leukemia
10:30¨C11 a.m.
The expansion of antibody drug conjugates
Assistant Professor, Investigational Cancer Therapeutics
Assistant Professor, Sarcoma Medical Oncology
11¨C11:30 a.m.
Integrative strategies for young-onset colorectal cancer, Part I
Chair and Professor, Colon and Rectal Surgery
Medical Director, Young-onset Colorectal Cancer Program
Professor, Colon & Rectal Surgery
11¨C11:30 a.m.
Advancing immunotherapy through novel combinations, Part I
Vice President, Head of Clinical Development, Therapeutics Discovery Division
Professor, Department of Investigational Cancer Therapeutics
11:30 a.m.¨C12 p.m.
Training at UT MD Anderson: Hematology/oncology fellowship
Program Director, Hematology/Oncology Fellowship Program
Associate Program Director, Research
Associate Professor, Thoracic/Head and Neck Medical Oncology
Hannah Goulart, M.D.
Fellow, Cancer Medicine
Associate Program Director, Hematology/Oncology Fellowship Program
12¨C12:30 p.m.
The gold standard in breast cancer treatment, Part II
Associate Professor, Breast Medical Oncology
Deputy Chair and Associate Professor, Breast Medical Oncology
12:30¨C1 p.m.
Integrative strategies for young-onset colorectal cancer, Part II
Associate Professor, Gastrointestinal Medical Oncology
1:45¨C2:15 p.m.
The gold standard in breast cancer treatment, Part II
Chair and Professor, Breast Medical Oncology
4¨C4:30 p.m.
The interception of cancer
Professor, Clinical Cancer Prevention
Professor, Gastrointestinal Medical Oncology
Monday, June 1
10¨C10:30 a.m.
Neoadjuvant therapy: Maximize cure and minimize harm
Professor, Radiation Oncology
10:45¨C11:15 a.m.
Liquid biopsies as decision tools in colorectal cancer
Professor, Gastrointestinal Medical Oncology
11:15¨C11:45 a.m.
Advancing immunotherapy through novel combinations, Part II
Professor, Investigational Cancer Therapeutics
11:30 a.m.¨C12 p.m.
Spotlight on sarcoma, Part II
Assistant Professor, Radiation Oncology
KRAS: Not just one target, Part II
11:30 a.m.¨C12 p.m.
Deputy Chair, Investigational Cancer Therapeutics
12¨C12:30 p.m.
Associate Professor, Thoracic/Head and Neck Medical Oncology
2¨C2:30 p.m.
Multi-cancer early detection tests: Are we ready?
Chair Ad Interim and Professor, Health Services Research
Professor, Breast Medical Oncology
Vice President, Cancer Prevention and Population Sciences